Adia Nutrition's subsidiary Adia Med is exploring international expansion after receiving significant global interest in its umbilical cord blood stem cell therapies. The company has consulted legal experts, confirmed regulatory feasibility, and identified a potential international location for its first clinic outside the US. Their flagship product, Adia Vita, has attracted attention for its potency in regenerative medicine.